US Bancorp
BIOA

US Bancorp’s BioAge Labs BIOA Stock Holding History

US Bancorp’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.78K Buy
216
+94
+77% +$1.81K ﹤0.01% 3649
2025
Q4 		$1.61K Buy
+122
New +$1.08K ﹤0.01% 3791

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

US Bancorp's BIOA Position: Q1 2026 in Review

US Bancorp increased its BioAge Labs (BIOA) stake by 77% in Q1 2026, buying an estimated $1.81K and bringing the position to 216 shares worth $3.78K. The position accounts for ﹤0.01% of the portfolio, ranked #3649.

US Bancorp first reported a position in BIOA in Q4 2025 and has held it in 2 quarters since. 144 funds tracked by Wall St. Rank hold BIOA as of Q1 2026.

  • US Bancorp held 216 shares of BioAge Labs worth $3.78K as of Q1 2026.
  • US Bancorp bought 94 BioAge Labs shares in Q1 2026, an estimated $1.81K.
  • BioAge Labs made up ﹤0.01% of US Bancorp's portfolio in Q1 2026, its #3649 holding.
  • US Bancorp first reported a position in BioAge Labs in Q4 2025 and has held it in 2 quarters since.
  • 144 funds tracked by Wall St. Rank held BioAge Labs as of Q1 2026.

Based on US Bancorp's 13F filing for Q1 2026, filed 15 May 2026.